Authors:
Tamás Kullmann Department of Medical Oncology, Hôpital Saint Louis, Paris, France
Service d'Oncologie Médicale, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010, Paris, France

Search for other papers by Tamás Kullmann in
Current site
Google Scholar
PubMed
Close
and
Jean-Louis Misset Department of Medical Oncology, Hôpital Saint Louis, Paris, France

Search for other papers by Jean-Louis Misset in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract

Mammographic breast screening is one of the most popular cancer death preventive programmes worldwide and in Hungary as well. Breast cancer mortality and incidence started to decrease some years after introduction of the screening programme. The role played by mammography in the advantageous turn is not known. Potential points in evaluating the benefits of a screening programme are reviewed. The average lifetime gain is put into focus. For mammography, it does not exceed 1–3 weeks, according to age groups.

  • [1]. L. Esserman Y. Shieh I. Thompson 2009 Rethinking screening for breast cancer and prostate cancer JAMA 302 16851692.

  • [2]. A. Kovács L. Döbrőssy A. Budai I. Boncz A. Cornides 2007 Az emlőszűrés helyzete Magyarországon 2006- ban Orv. Hetil. 148 879885.

    • Search Google Scholar
    • Export Citation
  • [3]. US Preventive Services Task Force 2009 Screening for breast cancer: US Preventive Services Task Force Recommendation Statement Ann. Intern. Med. 151 716726.

    • Search Google Scholar
    • Export Citation
  • [4]. C. J. Rosenquist K. K. Lindfors 1994 Screening mammography in women aged 40–49 years: analysis of costeffectiveness Radiology 191 647650.

    • Search Google Scholar
    • Export Citation
  • [5]. Gøtzsche, P., Nielsen, M.: Screening for breast cancer with mammography. Cochrane database, Available at: http://www.cochrane.org/reviews/en/ab001877.html.

    • Search Google Scholar
    • Export Citation
  • [6]. P. Gøtzsche O. Olsen 2000 Is screening for breast cancer with mammography justifiable? Lancet 355 129134.

  • [7]. L. Nystrom I. Andersson N. Bjurstam J. Frisell B. Nordenskjöld L. E. Rutqvist 2002 Long-term effects of mammography screening: updated overview of the Swedish randomized trials Lancet 359 909919.

    • Search Google Scholar
    • Export Citation
  • [8]. L. Nystrom 2000 Correspondence Lancet 355 748749.

  • [9]. R. Peto J. Boreham M. Clarke C. Davies V. Beral 2000 UK and USA breast cancer death down 25% in year 2000 at ages 20–69 years Lancet 355 1822.

    • Search Google Scholar
    • Export Citation
  • [10]. D. A. Berry K. A. Cronin S. K. Plevritis D. G. Fryback L. Clarke M. Zelen J. S. Mandelblatt A. Y. Yakovlev J. D. Habbema E. J. Feuer 2005 Effect of screening and adjuvant therapy on mortality from breast cancer N. Eng. J. Med. 353 17841792.

    • Search Google Scholar
    • Export Citation
  • [11]. L. Nystrom L. G. Larsson S. Wall L. E. Rutqvist I. Andersson N. Bjurstam G. Fagerberg J. Frisell L. Tabar 1996 An overview of the Swedish randomized mammography trials: total mortality pattern and the representativity of the study cohorts J. Med. Screening 3 8587.

    • Search Google Scholar
    • Export Citation
  • [12]. H. D. Nelson K. Tyne A. Naik C. Bougatsos B. K. Chan L. Humphrey US Preventive Services Task Force 2009 Screening for breast cancer: an update for the US Preventive Services Task Force Ann. Intern. Med. 151 727737.

    • Search Google Scholar
    • Export Citation
  • [13]. B. Döbrőssy A. Kovács A. Budai A. Cornides L. Döbrőssy 2007 A szűrés nemkívánatos lélektani mellékhatásai Orv. Hetil. 148 17071711.

    • Search Google Scholar
    • Export Citation
  • [14]. S. Zackrisson I. Andersson L. Janzon J. Manjer J. P. Garne 2006 Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study BMJ 332 689692.

    • Search Google Scholar
    • Export Citation
  • [15]. P. H. Zahl J. Moehlen H. G. Welch 2008 The natural history of invasive breast cancers detected by screening mammography Arch. Intern. Med. 168 23112316.

    • Search Google Scholar
    • Export Citation
  • [16]. J. Bonneterre V. Diéras 2007 Cancéro Guide, Sein Margaux Orange Paris.

  • Collapse
  • Expand

Clinical and Experimental Medical Journal
Language English
Size  
Year of
Foundation
2007
Publication
Programme
ceased
Volumes
per Year
 
Issues
per Year
 
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2060-6249 (Print)
ISSN 2060-968X (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Nov 2023 1 5 0
Dec 2023 17 0 0
Jan 2024 14 0 1
Feb 2024 25 0 0
Mar 2024 26 0 0
Apr 2024 6 0 0
May 2024 0 0 0